CITIGLAD ( 4 ml )


( Citicoline 250 mg/mL Injection IP )
Product Overview


CITIGLAD-4ml is a neuroprotective injection containing Citicoline 250 mg/mL, compliant with Indian Pharmacopoeia (IP) standards. Designed for intramuscular (I.M.) or intravenous (I.V.) administration, it aids in cellular repair and cognitive restoration following brain injuries, strokes, or neurological disorders.
Key Ingredient & Its Benefits
Citicoline 250 mg/mL
Neuronal Membrane Repair: Enhances phospholipid synthesis to repair damaged brain cells.
Antioxidant Action: Reduces oxidative damage caused by free radicals.
Cognitive Enhancement: Boosts production of neurotransmitters like acetylcholine and dopamine.
Rapid Bioavailability: Achieves therapeutic levels within 15–30 minutes via I.M./I.V. routes.
How CITIGLAD-4ml Works
Cellular Energy Boost: Increases ATP production to fuel brain cells.
Reduces Inflammation: Controls oxidative stress and neuroinflammation.
Neuroplasticity Support: Promotes new neural connections for long-term brain health.
Indications
CITIGLAD-4ml is used to manage:
Ischemic Stroke (disrupted blood supply to the brain).
Traumatic Brain Injury (TBI) or post-neurological damage recovery.
Cognitive Impairment (dementia, Alzheimer’s, age-related memory decline).
Glaucoma or optic nerve disorders as adjuvant therapy.
Use only under the guidance of a neurologist or physician.
Recommended Usage
Dosage:
Acute Cases (Stroke/Injury): 1000–2000 mg/day (4–8 mL) I.V., divided into 2 doses.
Chronic Cases (Dementia): 500–1000 mg/day (2–4 mL) I.M., once daily.
Administration:
I.V.: Dilute in 100 mL saline/dextrose and infuse over 30–45 minutes.
I.M.: Inject slowly into deep muscles (e.g., gluteus).
Duration: 2–6 weeks, adjusted based on patient progress and doctor’s advice.
Key Benefits
Dual Administration Routes
Flexibility for I.M. or I.V. use, tailored to patient needs.
Effective for Acute & Chronic Cases
Equally useful for post-stroke emergencies and long-term cognitive support.
Crosses the Blood-Brain Barrier (BBB)
Directly targets affected brain regions.
Clinically Validated
Safety and efficacy proven in 50+ studies.
Side Effects: Mild headache, nausea, or injection-site pain. Rarely, hypotension or allergies.
Contraindications: Hypersensitivity to citicoline or excipients. Use cautiously in Parkinson’s disease.
Drug Interactions: Monitor with anticoagulants (e.g., warfarin).
Storage: Below 25°C; protect from light. Use within 6 hours of opening.
Why Choose CITIGLAD - 4ml ?
Gold Standard in Neurorepair: Trusted for neuronal damage recovery.
Flexible Dosage: 250 mg/mL concentration suits diverse patient needs.
IP-Certified Quality: Manufactured under Indian Pharmacopoeia guidelines.
Cost-Effective: Affordable compared to other neuroprotective agents.
This information is for educational purposes only. Treatment decisions must be made by a qualified physician based on the patient’s condition. Do not adjust dosage without medical advice.
“Revitalize Brain Function, Restore Neurological Health”
Safety & Precautions
Our Process
Research Development
1
2
Quality Assurance
3
Global Standards
At Spirzen Life Sciences, we prioritize advanced research and development to create innovative pharmaceutical solutions that meet the highest global healthcare standards.
Our commitment to quality assurance ensures that every product adheres to strict regulations set by DCGI, FDA, WHO-GMP, and ISO 9001:2015 for optimal safety and efficacy.
We offer a diverse product range across various therapeutic areas, including neurology, cardiology, nephrology, and more, ensuring comprehensive healthcare solutions for all.
Get in Touch
For inquiries about our products or partnerships, please contact Spirzen Life Sciences. We are committed to providing accessible healthcare solutions and welcome your questions and feedback.